| abstract |
The present invention relates to an optical pure quinazoline compound, especially to a compound of the general formula (I), a process of preparing it, a pharmaceutical composition containing the same and the use thereof, wherein R1 and Y are defined as in the specification. It also involves a compound of the general formula (VII), which is an intermediate in the synthesis of the compound of the general formula (I), wherein Ar, R2, R3, m, n, T and Carbon atom with * are defined as in the specification. |